Trump to Announce Emergency Authorization of Convalescent Plasma to Treat COVID-19
President Donald Trump will announce on Sunday that a new coronavirus treatment involving blood plasma donated by people who’ve recovered from the disease has received an emergency use authorization from U.S. regulators.
Trump will make the announcement at a press conference due to start at 5:30 p.m. EDT, said two people familiar with the situation who weren’t authorized to speak publicly.
The U.S. Food and Drug Administration is expected to clear for use with certain patients what’s known as convalescent plasma. The move would make it easier for patients to get the product, which Trump has touted even though its effectiveness hasn’t been proved.
President Donald Trump is set to unveil Sunday night what his press secretary described as a “major therapeutic breakthrough” on COVID-19.
In a Saturday night tweet, White House press secretary Kayleigh McEnany said Trump would announce details at a 6 p.m. briefing on Sunday.
“News conference with President @realDonaldTrump at 6 pm tomorrow concerning a major therapeutic breakthrough on the China Virus,” she wrote, adding that Health and Human Services Secretary Alex Azar and Dr. Stephen Hahn, the commissioner of the Food and Drug Administration, would attend.
The disclosure came hours after the president called out the FDA for “making it very difficult for drug companies to get people in order to test the vaccines and therapeutics,” suggesting it was playing politics.
By Cathy Burke